Urban N, Tsitsipatis D, Hausig F, Kreuzer K, Erler K, Stein V, Ristow M, Steinbrenner H, Klotz LO
Thus, dapagliflozin was developed by AstraZeneca and Bristol Myers Squibb Company as a selective SGLT2 inhibitor for the treatment of T2DM, effectively lowering plasma glucose levels and glycosylated hemoglobin and improving glycemic control and body weight reduction ( Galega officinalis , which contains guanidine and its derivatives compounds that served as the foundation for metformins synthesis ( -glucosidase inhibitors and dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors)
(PubMed) Oliai Araghi S, Kiefte-de Jong JC, van Dijk SC, et al
It is reviewed periodically against current research
How to Include It in Your Routine Great skin rarely comes from a single habit
L-theanine's unique effects on the brain stem from its ability to regulate neural activity